Mingbo Su
Impact in
- Organic Chemistry top 5%
- Click Chemistry and Applications
- Synthesis and biological activity
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Metabolism, Diabetes, and Cancer
- Epigenetics and DNA Methylation
Papers in
-
- Histone Deacetylase Inhibitors Research 19
- Protein Degradation and Inhibitors 11
- Epigenetics and DNA Methylation 6
- Metabolism, Diabetes, and Cancer 3
- Oncology 15
- Peptidase Inhibition and Analysis 15
- Co-authors
- Jia Li (32 shared papers)Fajun Nan (7 shared papers)Yubo Zhou (16 shared papers)Wei Lü (8 shared papers)Jing-Ya Li (4 shared papers)Li-Fang Yu (5 shared papers)Yi Chen (6 shared papers)Xuan Zhang (5 shared papers)
- Journals
- European Journal of Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry (6 papers)Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)ACS Medicinal Chemistry Letters (3 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Mingbo Su
43 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 89
- Organic Chemistry 395
- Molecular Biology 827
- Endocrinology, Diabetes and Metabolism 153
- Toxicology 32
- Oncology 196
Countries citing papers authored by Mingbo Su
This map shows the geographic impact of Mingbo Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingbo Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingbo Su more than expected).
Fields of papers citing papers by Mingbo Su
This network shows the impact of papers produced by Mingbo Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingbo Su. The network helps show where Mingbo Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingbo Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 167 | |
| 2 | 2008 | 140 | |
| 3 | 2012 | 89 | |
| 4 | 2015 | 71 | |
| 5 | 2013 | 63 | |
| 6 | 2013 | 63 | |
| 7 | 2013 | 54 | |
| 8 | 2013 | 43 | |
| 9 | 2016 | 42 | |
| 10 | 2014 | 37 | |
| 11 | 2022 | 36 | |
| 12 | 2019 | 34 | |
| 13 | 2014 | 33 | |
| 14 | 2017 | 33 | |
| 15 | 2020 | 33 | |
| 16 | 2013 | 31 | |
| 17 | 2014 | 27 | |
| 18 | 2019 | 26 | |
| 19 | 2014 | 24 | |
| 20 | 2022 | 24 |
About Mingbo Su
Mingbo Su is a scholar working on Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (19 papers), Peptidase Inhibition and Analysis (15 papers), Diabetes Treatment and Management (12 papers), Protein Degradation and Inhibitors (11 papers), Neuropeptides and Animal Physiology (8 papers), Click Chemistry and Applications (6 papers), Epigenetics and DNA Methylation (6 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Organic Chemistry (395 citations), Molecular Biology (827 citations), Endocrinology, Diabetes and Metabolism (153 citations), Toxicology (32 citations) and Oncology (196 citations). Mingbo Su has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Jia Li, Fajun Nan, Yubo Zhou, Wei Lü, Jing-Ya Li, Li-Fang Yu, Yi Chen, Xuan Zhang, Tao Pang and Yi Zang. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.